BioAge Labs, Inc. SEC filings

Filings

Every filing, newest first. MAJOR and NOTABLE filings lead the app's feed; ROUTINE ones are kept here.

1. ROUTINE8-KBioAge Labs, Inc.BIOAOct 2

   BioAge Labs initiates Phase 2 trial for BGE-102

   • First participant dosed in QUELL-DME trial on 2026-10-02
   • Trial involves 180 participants with diabetic macular edema
   • Primary endpoint is visual acuity improvement at week 12
2. ROUTINESCHEDULE 13G/ABioAge Labs, Inc.BIOAAug 14

   Ownership stake disclosure by Cormorant Asset Management, LP (amended)

   Cormorant Asset Management, LP, filed by

3. NOTABLE10-QBioAge Labs, Inc.BIOAAug 5

   Quarterly report

4. ROUTINE8-KBioAge Labs, Inc.BIOAAug 5

   Current report

5. ROUTINE4BioAge Labs, Inc.BIOAJul 1

   Shane Barton, insider filing for BIOA

   Shane Barton, reporting

6. ROUTINE144BioAge Labs, Inc.BIOAJun 30

   Shane Barton, planned sale of BIOA shares

   Shane Barton, reporting

7. ROUTINE144BioAge Labs, Inc.BIOAJun 29

   Shane Barton, planned sale of BIOA shares

   Shane Barton, reporting

8. ROUTINE4BioAge Labs, Inc.BIOAJun 12

   6 insider filings

   Vijay Satyanand Pande, insider filing for BIOA

   Show all 6

   • 4Insider filing for BIOAJun 12
   • 4Insider filing for BIOAJun 12
   • 4Insider filing for BIOAJun 12
   • 4Insider filing for BIOAJun 12
   • 4Insider filing for BIOAJun 12
   • 4Insider filing for BIOAJun 12

   Vijay Satyanand Pande, reporting

9. ROUTINE8-KBioAge Labs, Inc.BIOAJun 12

   Current report

10. ROUTINESCHEDULE 13G/ABioAge Labs, Inc.BIOAMay 15

    Ownership stake disclosure by Khosla Ventures VI, L.P. (amended)

    Khosla Ventures VI, L.P., filed by

11. ROUTINESCHEDULE 13G/ABioAge Labs, Inc.BIOAMay 15

    Ownership stake disclosure by Cormorant Asset Management, LP (amended)

    Cormorant Asset Management, LP, filed by

12. ROUTINE8-KBioAge Labs, Inc.BIOAMay 8

    Current report

13. NOTABLE10-QBioAge Labs, Inc.BIOAMay 8

    Quarterly report

14. ROUTINESCHEDULE 13GBioAge Labs, Inc.BIOAApr 27

    Ownership stake disclosure by BlackRock, Inc.

    BlackRock, Inc., filed by

15. ROUTINE4BioAge Labs, Inc.BIOAApr 24

    Dov A Md Goldstein, insider filing for BIOA

    Dov A Goldstein Md, reporting

16. ROUTINEARSBioAge Labs, Inc.BIOAApr 21

    Annual report to shareholders

17. ROUTINEDEFA14ABioAge Labs, Inc.BIOAApr 21

    Additional proxy materials

18. ROUTINEDEF 14ABioAge Labs, Inc.BIOAApr 21

    Proxy statement

19. ROUTINE4BioAge Labs, Inc.BIOAApr 3

    Paul D Rubin, insider filing for BIOA

    Paul D Rubin, reporting

20. ROUTINE144BioAge Labs, Inc.BIOAApr 1

    Paul D Rubin, planned sale of BIOA shares

    Paul D Rubin, reporting

21. ROUTINES-3ASRBioAge Labs, Inc.BIOAMar 24

    Securities offering

22. ROUTINES-8BioAge Labs, Inc.BIOAMar 24

    Employee stock plan registration

23. NOTABLE10-KBioAge Labs, Inc.BIOAMar 24

    Annual report

24. ROUTINE8-KBioAge Labs, Inc.BIOAMar 24

    Current report

25. ROUTINE4BioAge Labs, Inc.BIOAMar 3

    2 insider filings

    Dov A Md Goldstein, insider filing for BIOA

    Show all 2

    • 4Insider filing for BIOAMar 3
    • 4Insider filing for BIOAMar 3

    Dov A Goldstein Md, reporting

26. ROUTINE144BioAge Labs, Inc.BIOAMar 2

    Paul D Rubin, planned sale of BIOA shares

    Paul D Rubin, reporting

27. ROUTINE4BioAge Labs, Inc.BIOAFeb 19

    5 insider filings

    Paul D Rubin, insider filing for BIOA

    Show all 5

    • 4Insider filing for BIOAFeb 19
    • 4Insider filing for BIOAFeb 19
    • 4Insider filing for BIOAFeb 19
    • 4Insider filing for BIOAFeb 19
    • 4Insider filing for BIOAFeb 19

    Paul D Rubin, reporting

28. ROUTINESCHEDULE 13G/ABioAge Labs, Inc.BIOAFeb 17

    Ownership stake disclosure by ADAR1 Capital Management, LLC (amended)

    ADAR1 Capital Management, LLC, filed by

29. ROUTINESCHEDULE 13G/ABioAge Labs, Inc.BIOAFeb 17

    Ownership stake disclosure by Cormorant Asset Management, LP (amended)

    Cormorant Asset Management, LP, filed by

30. ROUTINESCHEDULE 13G/ABioAge Labs, Inc.BIOAFeb 13

    Ownership stake disclosure by Kristen Fortney (amended)

    Kristen Fortney, filed by

31. ROUTINE4BioAge Labs, Inc.BIOAFeb 3

    2 insider filings

    Paul D Rubin, insider filing for BIOA

    Show all 2

    • 4Insider filing for BIOAFeb 3
    • 4Insider filing for BIOAFeb 3

    Paul D Rubin, reporting

32. ROUTINE144BioAge Labs, Inc.BIOAFeb 2

    Paul D Rubin, planned sale of BIOA shares

    Paul D Rubin, reporting

33. ROUTINE8-KBioAge Labs, Inc.BIOAJan 22

    Current report

34. ROUTINE424B5BioAge Labs, Inc.BIOAJan 22

    Securities offering

35. ROUTINE4BioAge Labs, Inc.BIOAJan 21

    Dov A Md Goldstein, insider filing for BIOA

    Dov A Goldstein Md, reporting

36. ROUTINE424B5BioAge Labs, Inc.BIOAJan 20

    Securities offering

37. ROUTINE8-KBioAge Labs, Inc.BIOAJan 20

    Current report

38. ROUTINE4BioAge Labs, Inc.BIOAJan 15

    2 insider filings

    Dov A Md Goldstein, insider filing for BIOA

    Show all 2

    • 4Insider filing for BIOAJan 15
    • 4Insider filing for BIOAJan 15

    Dov A Goldstein Md, reporting

Older filings on EDGAR